Cargando…

Gonadotropin releasing hormone analogue treatment of central precocious puberty is not associated with altered prevalence of polycystic ovary syndrome: a single center cohort study

BACKGROUND: There is conflicting evidence regarding an association between gonadotropin releasing hormone analogue (GnRHa) therapy and polycystic ovary syndrome (PCOS). This study aimed to compare the prevalence of endocrine disorders, primarily PCOS, between women who had been treated with GnRHa fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karavani, Gilad, Chill, Henry H., Schachter-Safrai, Natali, Lomnitz, Gan, Gillis, David, Bauman, Dvora
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442439/ https://www.ncbi.nlm.nih.gov/pubmed/34521474 http://dx.doi.org/10.1186/s40842-021-00129-4

Ejemplares similares

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

Body image and depression in girls with idiopathic precocious puberty treated with gonadotropin-releasing hormone analogue
por: Choi, Min-Seon, et al.
Publicado: (2016)

Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls
por: Shi, Yuzhen, et al.
Publicado: (2022)

Final height outcome of boys with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogue
por: Ma, Hua-mei, et al.
Publicado: (2013)

Effect of gonadotropin-releasing hormone analogue on final adult height among Jordanian children with precocious puberty
por: Swaiss, Hala H., et al.
Publicado: (2017)

The genes associated with gonadotropin-releasing hormone-dependent precocious puberty
por: Hwang, Jin Soon
Publicado: (2012)

The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years
por: Korkmaz, Ozlem, et al.
Publicado: (2019)

Correction to: The Gonadotropin-Releasing Hormone Analogue Therapy May Not Impact Final Height in Precocious Puberty of Girls With Onset of Puberty Aged 6 - 8 Years
por: Korkmaz, Ozlem, et al.
Publicado: (2019)

Long-term effects of gonadotropin-releasing hormone analogs in girls with central precocious puberty
por: Kim, Eun Young
Publicado: (2015)

Treatment outcomes of gonadotropin-releasing hormone agonist in obese girls with central precocious puberty
por: Kim, Hye Ryun, et al.
Publicado: (2017)

The influence of gonadotropin-releasing hormone agonists on anthropometric change in girls with central precocious puberty
por: Yoon, Jong Wan, et al.
Publicado: (2017)

Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States
por: Popovic, Jadranka, et al.
Publicado: (2022)

Analysis of the efficacy of Dabuyin pill combined with gonadotropin-releasing hormone analogue in the treatment of central precocious puberty girls based on network pharmacology
por: Chen, Xiaohong, et al.
Publicado: (2023)

Leydig Cell Tumor-Induced Gonadotropin-Independent Precocious Puberty Progressing to Gonadotropin-Dependent Precocious Puberty Post Orchiectomy: Out of the Frying Pan Into the Fire
por: Singhania, Pankaj, et al.
Publicado: (2022)

Chemotherapy-based gonadotoxicity risk evaluation as a predictor of reproductive outcomes in post-pubertal patients following ovarian tissue cryopreservation
por: Karavani, Gilad, et al.
Publicado: (2021)

Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty
por: Yang, Eun Hye, et al.
Publicado: (2023)

Final height after gonadotropin-releasing hormone agonists with or without growth hormone in Korean girls with central precocious puberty and early puberty
por: Kwon, Eun Byul, et al.
Publicado: (2015)

Gonadotropin-Dependent Precocious Puberty: Neoplastic Causes and Endocrine Considerations
por: Stephen, Matthew D, et al.
Publicado: (2011)

Precocious puberty due to human chorionic gonadotropin secreting germinoma
por: Nascimento, Daiane J., et al.
Publicado: (2012)

Etiology and therapeutic outcomes of children with gonadotropin-independent precocious puberty
por: Kang, Eungu, et al.
Publicado: (2016)

Transient Arterial Hypertension Induced by Gonadotropin-Releasing Hormone Agonist Treatment for Central Precocious Puberty
por: Sifaki, Loukia, et al.
Publicado: (2019)

Gonadotropin-releasing hormone stimulation test and diagnostic cutoff in precocious puberty: a mini review
por: Ab Rahim, Siti Nadirah, et al.
Publicado: (2020)

Clinical and Laboratory Parameters of Gonadotropin-Releasing Hormone Analog Treatment Effectiveness in Children with Precocious Puberty
por: Fujita, Lívia Grimaldi Abud, et al.
Publicado: (2019)

A Case of Nonalcoholic Steatohepatitis in Central Precocious Puberty Aggravated by Gonadotropin-releasing Hormone Analog
por: Sasaki, Yoshiaki, et al.
Publicado: (2020)

Abstract 54: Clinical and biochemical outcomes of gonadotropin -Releasing hormone analogue therapy in a cohort of children with central precocious puberty from Kerala
por: Bhandarkar, Akhila, et al.
Publicado: (2022)

Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone
por: Jung, Mo Kyung, et al.
Publicado: (2014)

Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty
por: Lee, Hae Sang, et al.
Publicado: (2016)

Influence of Gonadotropin Hormone Releasing Hormone Agonists on Interhemispheric Functional Connectivity in Girls With Idiopathic Central Precocious Puberty
por: Chen, Tao, et al.
Publicado: (2020)

Significant adverse reactions to long-acting gonadotropin-releasing hormone agonists for the treatment of central precocious puberty and early onset puberty
por: Lee, Ji Woo, et al.
Publicado: (2014)

Commentary on "Effect of gonadotropin-releasing hormone agonist treatment on near final height in girls with central precocious puberty and early puberty"
por: Kwon, Ahreum
Publicado: (2023)

Factors to Predict Positive Results of Gonadotropin Releasing Hormone Stimulation Test in Girls with Suspected Precocious Puberty
por: Nam, Hyo-Kyoung, et al.
Publicado: (2012)

Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty
por: Lee, Hae Sang, et al.
Publicado: (2018)

Prevalence of idiopathic scoliosis in girls with central precocious puberty: effect of a gonadotropin-releasing hormone agonist
por: Chung, Lindsey Yoojin, et al.
Publicado: (2020)

Long-term outcomes after gonadotropin-releasing hormone agonist treatment in boys with central precocious puberty
por: Shim, Young Suk, et al.
Publicado: (2020)

Clinical data and basal gonadotropins in the diagnosis of central precocious puberty in girls
por: Durá-Travé, Teodoro, et al.
Publicado: (2021)

The influence of gonadotropin releasing hormone agonist treatment on the body weight and body mass index in girls with idiopathic precocious puberty and early puberty
por: Kim, Sung Woo, et al.
Publicado: (2017)

Precocious Puberty in the Female in Association with Chorion-Carcinoma of the Ovary
Publicado: (1933)

The role of gonadotropin‐releasing hormone neurons in polycystic ovary syndrome
por: McCartney, Christopher R., et al.
Publicado: (2022)

Effects of Gonadotropin-Releasing Hormone Agonist Therapy on Body Mass Index and Height in Girls with Central Precocious Puberty
por: Lee, Seung Jae, et al.
Publicado: (2012)

Gonadotropin Releasing Hormone Agonist Treatment to Increase Final Stature in Children With Precocious Puberty: A Meta-Analysis
por: Li, Pin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_earjb5oq4sp5d1h2nstcgh4626